| Literature DB >> 30459586 |
Saúl J Ruiz-Gómez1, Carlos Gómez1, Jesús Poza1,2,3, Mario Martínez-Zarzuela4, Miguel A Tola-Arribas5, Mónica Cano6, Roberto Hornero1,2,3.
Abstract
Alzheimer's Disease (AD) represents the most prevalent form of dementia and is considered a major health problem due to its high prevalence and its economic costs. An accurate characterization of the underlying neural dynamics in AD is crucial in order to adopt effective treatments. In this regard, mild cognitive impairment (MCI) is an important clinical entity, since it is a risk-state for developing dementia. In the present study, coupling patterns of 111 resting-state electroencephalography (EEG) recordings were analyzed. Specifically, we computed Cross-Approximate Entropy (Cross-ApEn) and Cross-Sample Entropy (Cross-SampEn) of 37 patients with dementia due to AD, 37 subjects with MCI, and 37 healthy control (HC) subjects. Our results showed that Cross-SampEn outperformed Cross-ApEn, revealing higher number of significant connections among the three groups (Kruskal-Wallis test, FDR-corrected p-values < 0.05). AD patients exhibited statistically significant lower similarity values at θ and β1 frequency bands compared to HC. MCI is also characterized by a global decrease of similarity in all bands, being only significant at β1. These differences shows that β band might play a significant role in the identification of early stages of AD. Our results suggest that Cross-SampEn could increase the insight into brain dynamics at different AD stages. Consequently, it may contribute to develop early AD biomarkers, potentially useful as diagnostic information.Entities:
Keywords: Alzheimer's disease; cross-entropy metrics; electroencephalography (EEG); mild cognitive impairment; neural coupling
Year: 2018 PMID: 30459586 PMCID: PMC6232874 DOI: 10.3389/fninf.2018.00076
Source DB: PubMed Journal: Front Neuroinform ISSN: 1662-5196 Impact factor: 4.081
Socio-demographic and clinical data for each group in the training set.
| Number of subjects | 20 | 20 | 20 |
| Number of trials | 912 | 937 | 917 |
| Age (years) (median[IQR]) | 75.6[74.1, 77.6] | 77.9[67.9, 79.8] | 80.7[74.7, 78.9] |
| Gender (Male:Female) | 8:12 | 8:12 | 5:15 |
| MMSE | 29[28, 30] | 27.5[26.5, 29] | 21[18.5, 22.5] |
| B-ADL | 1.1[1.0, 1.2] | 2.9[2.4, 3.3] | 5.8[5.1, 7.2] |
| Education level (A:B) | 5:15 | 11:9 | 8:12 |
MMSE, Mini Mental State Examination;
B-ADL, Bayer-Activities of Daily Living;
A, Primary education or below; B, Secondary education or above.
Socio-demographic and clinical data for each group in the test set.
| Number of subjects | 17 | 17 | 17 |
| Number of trials | 752 | 847 | 757 |
| Age (years) (median[IQR]) | 76.4[73.6, 78.9] | 75.3[69.8, 82.0] | 82.4[77.7, 83.9] |
| Gender (Male:Female) | 4:13 | 8:9 | 7:10 |
| MMSE | 29[28, 30] | 27[27, 28] | 22[20, 24] |
| B-ADL | 1.2[1.0, 1.3] | 2.8[2.3, 2.5] | 6.4[5.0, 7.3] |
| Education level (A:B) | 5:12 | 12:5 | 10:7 |
MMSE, Mini Mental State Examination;
B-ADL, Bayer-Activities of Daily Living;
A, Primary education or below; B, Secondary education or above.
Total number of significant connections among the three groups (FDR-corrected p-values < 0.05, Kruskal-Wallis test) for each parameter combination in the training set.
| 182 | 0 | 468 | 0 | |
| 486 | 213 | 508 | 12 | |
| 403 | 228 | 514 | 48 | |
| 349 | 255 | 502 | 196 | |
Optimal FCBF sets of features for HC vs. MCI and HC vs. AD comparisons.
| Fz-T4 (δ) | Cz-C3 (θ) | C4-Fp2 (α) | P3-Fz (β1) | |
| F7-Fp2 (δ) | Fp1-C3 (θ) | T3-T5 (θ) | C3-Pz (γ) | |
Figure 1Cross-SampEn results for HC vs. MCI comparison at β1 band. Left and central columns depict Cross-SampEn values for controls and MCI patients, respectively. Right column displays statistical results, where connections were only displayed when statistically significant differences were obtained (FDR-corrected p-values < 0.05, Mann-Whitney U-test). Red color tones indicate significant Cross-SampEn increases in MCI compared with controls, whereas blue color tones denote significant decreases.
Figure 2Cross-SampEn results for HC vs. AD comparison (A) at θ band, and (B) at β1 band. Left and central columns depict Cross-SampEn values for controls and AD patients, respectively. Right column displays statistical results, where connections were only displayed when statistically significant differences were obtained (FDR-corrected p-values < 0.05, Mann-Whitney U-test). Red color tones indicate significant Cross-SampEn increases in AD compared with controls, whereas blue color tones denote significant decreases.